Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy
Basel, February 13, 2026 – Novartis today announced final results from the…
TraceLink Earns Top-Tier ISO, SOC, and CyberVadis Results, Confirming Its Position as the Most Trusted Agentic Orchestration Platform for Life Sciences
Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and…
Samsung Plans to Bring Google Photos to Samsung AI TV Lineup, Helping Users Relive Their Favorite Memories on the Big Screen
Samsung TV aims to be the first to launch Google Photos features…
U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Radware Reports Results of 2025 Annual General Meeting
December 23, 2025 06:01 ET | Source: Radware Ltd. TEL AVIV, Israel,…
Burning Rock Announces Results of 2025 Annual General Meeting
GUANGZHOU, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited…
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
– Company to host live webcast and conference call Monday, December 15,…
FitLine x Paris Basketball: Performance and Results at the Highest Level
LUXEMBOURG and PARIS, Dec. 10, 2025 /PRNewswire/ -- FitLine is proud to…